Patents by Inventor Cristiano Migliorini

Cristiano Migliorini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AMINODIHYDROTHIAZINES FOR THE TREATMENT OR PREVENTION OF DIABETES
    Publication number: 20140221360
    Abstract: This invention relates to compounds of formula I, wherein R1 to R3 are as defined herein, as well as pharmaceutically acceptable salts thereof, pharmaceutical compositions containing such compounds and methods for using such compounds for the treatment or prevention of diabetes, particularly type 2 diabetes.
    Type: Application
    Filed: April 4, 2014
    Publication date: August 7, 2014
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Jeremy Beauchamp, Agnes Benardeau, Hans Hilpert, Cristiano Migliorini, William Riboulet, Haiyan Wang
  • Tmem27 antibody
    Patent number: 8512704
    Abstract: The present invention relates to an antibody directed to a beta cell marker protein, in particular to an antibody directed to the protein TMEM27.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: August 20, 2013
    Assignee: Genentech, Inc.
    Inventors: Kerstin Jahn-Hofmann, Sannah Zoffmann Jensen, Hugues Matile, Cristiano Migliorini, Haiyan Wang
  • MARKER PROTEIN FOR TYPE-2 DIABETES
    Publication number: 20120276561
    Abstract: The present invention provides a marker protein for the early detection of type II diabetes, antibodies directed to the marker protein and their use in a diagnostic method for type II diabetes and in drug development.
    Type: Application
    Filed: November 23, 2010
    Publication date: November 1, 2012
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Laura Badi, Martin Ebeling, Hugues Matile, Cristiano Migliorini, Jacob Sabates Bellver, Thomas Schindler, Elena Sebokova, Haiyan Wang
  • SCREENING ASSAYS FOR THE IDENTIFICATION OF BACE2 INHIBITORS
    Publication number: 20110229922
    Abstract: The present invention relates to screening assays for the identification of BACE2 inhibitors.
    Type: Application
    Filed: November 26, 2009
    Publication date: September 22, 2011
    Inventors: Jeremy Beauchamp, Heinz Doebeli, Hugues Matile, Cristiano Migliorini, Michael Prummer, Paolo Salvioni, Haiyan Wang